$94.97 +2.97 (%) Celgene Corp - NASDAQ

Oct. 21, 2014 | 04:00 PM

Partner Headlines

  1. Biogen Leads 5 Top Biotech Stocks As Earnings Loom

    IBD | Oct. 21, 2014 | 19:56PM EST
  2. Stocks Further Extend Gains; Airlines, Medicals Soar

    IBD | Oct. 21, 2014 | 15:01PM EST
  3. Celgene Reports More Good Crohn's Disease Data

    IBD | Oct. 21, 2014 | 11:32AM EST
  4. Celgene drug trial successful

    IBD | Oct. 20, 2014 | 18:57PM EST
  5. Celgene's Crohn's Disease Drug Hits Its Marks

    IBD | Oct. 20, 2014 | 11:16AM EST
  6. Phase II Data In Crohn's Disease For Celgene's Oral Antisense Therapy GED-0301 To Be Presented At UEG Week 2014

    Benzinga | Oct. 20, 2014 | 07:35AM EST
  7. Benzinga Weekly Preview: Earnings Season Is In Full Swing

    Benzinga | Oct. 19, 2014 | 10:19AM EST
  8. Celgene, Alexion Among 4 IBD 50 Medical s To Report

    IBD | Oct. 18, 2014 | 08:02AM EST
  9. Was Celgene's Crohn's Disease Drug Worth The Price?

    IBD | Oct. 15, 2014 | 17:39PM EST
  10. Apple, McKesson Among Big Caps In Trading Range

    IBD | Oct. 13, 2014 | 18:38PM EST
  11. Second Oldest Stock Fund Is As Nimble As A Teenager

    IBD | Oct. 2, 2014 | 18:25PM EST
  12. Top Fund Buys: Chipotle, Allergan, Jazz, Gilead

    IBD | Oct. 2, 2014 | 18:25PM EST
  13. Celgene Corporation Shares Could Head Higher

    Benzinga | Sep. 30, 2014 | 12:15PM EST
  14. Biotech Stocks Rebound On Strong Earnings, New Drugs

    IBD | Sep. 29, 2014 | 18:32PM EST
  15. Agios Pharmaceuticals Inc, Altria Group Inc Highlight CNBC's Stock Pops & Drops From September 26

    Benzinga | Sep. 27, 2014 | 10:33AM EST
  16. Agios drug data boosts stock

    IBD | Sep. 26, 2014 | 18:52PM EST
  17. Agios' Early Drug-Trial Report Cheers Wall Street

    IBD | Sep. 26, 2014 | 13:21PM EST
  18. Technology Stocks Slide But Other Sectors Hold Up Better

    IBD | Sep. 25, 2014 | 18:55PM EST
  19. Stocks Get Hit Hard; GoPro, Skechers Buck Weakness

    IBD | Sep. 25, 2014 | 16:23PM EST
  20. Apple Fuels Tech Sell-Off; Valeant Bucks The Trend

    IBD | Sep. 25, 2014 | 11:34AM EST
  21. Stocks Up In Afternoon; Hasbro Jumps On Disney Deal

    IBD | Sep. 24, 2014 | 15:05PM EST
  22. Stocks Rally To Session Highs; Celgene Leads Biotech Rally

    IBD | Sep. 24, 2014 | 11:49AM EST
  23. Celgene's

    IBD | Sep. 23, 2014 | 18:45PM EST
  24. IBD 50 Stocks Setting Up, Including These 5 Medicals

    IBD | Sep. 19, 2014 | 18:35PM EST
  25. Nasdaq Touches 52-Week High; Concur Soars On Buyout

    IBD | Sep. 19, 2014 | 11:50AM EST
  26. US Stock Futures Flat; All Eyes On FOMC Decision

    Benzinga | Sep. 17, 2014 | 07:19AM EST
  27. Deutsche Bank Is Bullish On Gilead Sciences, Inc. And Other Biotech Stocks

    Benzinga | Sep. 16, 2014 | 08:19AM EST
  28. Nasdaq Falls Hard, But Apple Resilient On iPhone Orders

    IBD | Sep. 15, 2014 | 14:55PM EST
  29. Nasdaq Underperforms As Leading Growth Stocks Take Heat

    IBD | Sep. 15, 2014 | 11:49AM EST
  30. Stocks Stumble At Open; Mobileye Rebounds

    IBD | Sep. 15, 2014 | 10:26AM EST
  31. 3 Companies Investing In Stem Cell Research

    Benzinga | Sep. 14, 2014 | 16:34PM EST
  32. Medivation Eyes Blockbuster As Cancer Drug Gets An OK

    IBD | Sep. 11, 2014 | 17:41PM EST
  33. Stocks Bounce As Nasdaq, S&P 500 Close With Small Gains

    IBD | Sep. 11, 2014 | 16:17PM EST
  34. Stocks Show Modest Losses; Biotechs Pressured Again

    IBD | Sep. 11, 2014 | 14:46PM EST
  35. Celgene Corporation Easing Back After Run To New All-Time Highs - Is It Buyable Yet?

    Benzinga | Sep. 11, 2014 | 08:07AM EST
  36. Allianz's Analyst Likes Biogen, Celgene & Gilead

    Benzinga | Sep. 6, 2014 | 17:28PM EST
  37. IBD 50 Showing Little Distress, But Few Big Winners

    IBD | Sep. 5, 2014 | 18:45PM EST
  38. #PreMarket Primer: Friday, September 5: US Labor Market Expected To Show Improvement

    Benzinga | Sep. 5, 2014 | 06:54AM EST
  39. Three Stocks Top-Performing Funds Like: Facebook Baidu Gilead

    IBD | Sep. 3, 2014 | 18:28PM EST
  40. Biotechnology, Oil And Brazil ETFs To Watch This Week

    Benzinga | Sep. 2, 2014 | 10:05AM EST
  41. 4 Biotechs That Might Be Bought Soon

    IBD | Aug. 29, 2014 | 11:53AM EST
  42. #PreMarket Primer: Thursday, August 28: Russia Implicated Further In Ukrainian Conflict

    Benzinga | Aug. 28, 2014 | 07:00AM EST
  43. Celgene rose 2.4%

    IBD | Aug. 26, 2014 | 18:45PM EST
  44. Stocks Rise As Biotechs Lead; Amazon To Buy Twitch

    IBD | Aug. 26, 2014 | 16:58PM EST
  45. Celgene, Gilead Lead Big Biotech Stock Movers

    IBD | Aug. 26, 2014 | 14:38PM EST
  46. Fast Money Traders Share The Stocks To Buy In An Uptrend Market

    Benzinga | Aug. 25, 2014 | 20:53PM EST
  47. Biogen, Celgene In Buy Range; LinkedIn Coming Back

    IBD | Aug. 25, 2014 | 18:43PM EST
  48. Stocks Rise As Biotechs Lead; Amazon To Buy Twitch

    IBD | Aug. 25, 2014 | 16:58PM EST
  49. Stocks Higher With Biotechs Leading The Way

    IBD | Aug. 25, 2014 | 16:34PM EST
  50. Stocks Hold Decent Gains; InterMune Deal Sparks Biotechs

    IBD | Aug. 25, 2014 | 14:54PM EST
Trading Center